Table 4 Administered beta-lactams at admission for patients with or without different macrolides and fluoroquinolones
Azithromycin (N = 151) | Clarithromycin (N = 222) | Erythromycin (N = 277) | Ciprofloxacin (N = 206) | Levofloxacin (N = 194) | Moxifloxacin (N = 554) | No macrolides or fluoroquinolones (N = 587) | |
|---|---|---|---|---|---|---|---|
Amoxicillin | 17 (11.0%) | 53 (22.3%) | 25 (8.4%) | 70 (34.0%) | 2 (1.0%) | 16 (2.9%) | 149 (25.4%) |
Amoxicillin/clavulanic acid | 37 (23.9%) | 148 (62.2%) | 33 (11.1%) | 69 (33.5%) | 6 (3.1%) | 18 (3.2%) | 291 (49.6%) |
Ceftriaxone | 72 (46.5%) | 17 (7.1%) | 31 (10.4%) | 30 (14.6%) | 4 (2.1%) | 28 (5.1%) | 95 (16.2%) |
Cefuroxime | 5 (3.2%) | 12 (5.0%) | 96 (32.2%) | 10 (4.9%) | 0 (0.0%) | 3 (0.5%) | 24 (4.1%) |
Cefotaxime | 0 (0.0%) | 1 (0.4%) | 3 (1.0%) | 1 (0.5%) | 0 (0.0%) | 0 (0.0%) | 1 (0.2%) |
Ceftazidime | 4 (2.6%) | 2 (0.8%) | 3 (1.0%) | 8 (3.9%) | 1 (0.5%) | 1 (0.2%) | 12 (2.0%) |
Penicillin | 5 (3.2%) | 10 (4.2%) | 146 (49.0%) | 20 (9.7%) | 8 (4.1%) | 10 (1.8%) | 9 (1.5%) |